Genomics Boom Continues

A new report estimates that the genomics research tools market will be worth nearly $9 billion by 2016.

Jef Akst
Jef Akst

Jef Akst is managing editor of The Scientist, where she started as an intern in 2009 after receiving a master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses.

View full profile.


Learn about our editorial policies.

Apr 16, 2012

ISTOCK, ALENGO

Los Angeles-based market-analysis company DeciBio predicts that the global genomics life science research tools market will grow some 6 percent over the next 5 years, reaching $8.9 billion by 2016, reported GenomeWeb Daily News. Part of this rise will be supported by the grown of the next-generation sequencing market, which DeciBio estimated to increase by 16 percent annually, reaching $2.25 billion by 2016, according to a new report published last week (April 12).

Genomics "is expected to be the fastest growing segment in the life science research tools space," Stéphane Budel, a partner in DeciBio, told GenomeWeb.

The report noted how technological advancements had driven down the price of genome sequencing from $3 billion a decade ago to just $3,000 today. In the future, such technologies will be applied more and more in a clinical setting, looking for disease-causing mutations in cancer biopsies, for example.

Other...

Interested in reading more?

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?